发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 63 |
| Italy | 11 |
| CHINA MAINLAND | 10 |
| England | 8 |
| France | 7 |
| South Korea | 6 |
| Spain | 6 |
| GERMANY (FED REP GER) | 4 |
| Austria | 3 |
| Belgium | 3 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| UNIVERSITY OF TEXAS SYSTEM | 15 |
| MAYO CLINIC | 7 |
| HARVARD UNIVERSITY | 6 |
| ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP) | 5 |
| CHINESE ACADEMY OF MEDICAL SCIENCES - PEKING U... | 4 |
| DANA-FARBER CANCER INSTITUTE | 4 |
| SEOUL ST. MARY'S HOSPITAL | 4 |
| CATHOLIC UNIVERSITY OF KOREA | 3 |
| OHIO STATE UNIVERSITY | 3 |
| UNIVERSITY OF LONDON | 3 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| CAR T-cell therapy for B-cell lymphomas: clinical trial ... | 41 |
| Emerging treatment paradigms with FLT3 inhibitors in acu... | 28 |
| New and emerging therapies for acute and chronic graft v... | 22 |
| Practical aspects of extended half-life products for the... | 21 |
| Epigenetic therapy combinations in acute myeloid leukemi... | 21 |
| Novel therapy in Acute myeloid leukemia (AML): moving to... | 20 |
| Gene therapy for hemophilia: what does the future hold? | 19 |
| Ravulizumab: a novel C5 inhibitor for the treatment of p... | 14 |
| Immunotherapy in myeloma: how far have we come? | 13 |
| Venetoclax for the treatment of newly diagnosed acute my... | 11 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| FRONT ONCOL | 12 |
| LEUKEMIA LYMPHOMA | 12 |
| BLOOD ADV | 11 |
| FRONT IMMUNOL | 11 |
| HAEMOPHILIA | 11 |
| THER ADV HEMATOL | 11 |
| BRIT J HAEMATOL | 10 |
| BLOOD REV | 9 |
| CANCERS | 9 |
| CELLS-BASEL | 9 |